Affinity reagents for the detection of modified RNAs and Transcriptome-wide mapping of RNA modifications

Information

  • Research Project
  • 8841953
  • ApplicationId
    8841953
  • Core Project Number
    R43DA038991
  • Full Project Number
    1R43DA038991-01
  • Serial Number
    038991
  • FOA Number
    RFA-DA-15-001
  • Sub Project Id
  • Project Start Date
    9/1/2014 - 10 years ago
  • Project End Date
    8/31/2016 - 8 years ago
  • Program Officer Name
    BOUGH, KRISTOPHER J.
  • Budget Start Date
    9/1/2014 - 10 years ago
  • Budget End Date
    8/31/2016 - 8 years ago
  • Fiscal Year
    2014
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/13/2014 - 10 years ago
Organizations

Affinity reagents for the detection of modified RNAs and Transcriptome-wide mapping of RNA modifications

DESCRIPTION (provided by applicant): Biological RNAs undergo extensive post-transcriptional modifications. These modifications are important in promoting the accuracy and efficiency of gene expression in biological systems. To decipher the functions of RNA modifications, robust analytical tools and methods that enable scientists to monitor, manipulate, and transcriptome-wide mapping RNA modifications are highly needed. In this multi-phase SBIR program, Guild Biosciences Inc. (GBS) proposes to address this issue by: 1) developing a library of affinity antibodies and peptide sequences specific to modified nucleosides by using phase-antibody display libraries and peptide phase-display library, 2) developing a novel immunoassay system- open immunocomplex assay with the developed antibodies and peptides for rapid and quantitative detection of modified nucleotides in RNA samples, and 3) incorporating the immunoprecipitation capability of the developed affinity reagents with next-generation sequencing platforms to develop method for global mapping of RNA modifications with high accuracy. Successful completion of the proposed research will add much needed analytical tools and methods in terms of affinity reagents, immunoassay systems and deep sequencing method, which will significantly expand the tool box for the epigenetic research. Several commercial viable products, such as affinity reagents (antibodies, peptides) recognizes the chemical structures of modified RNA nucleosides, bioassay kits for detection/quantitation of RNA modifications, and sequencing preparation kit for deep RNA sequencing will be generated as the ultimate outcome of this proposed research.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R43
  • Administering IC
    DA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    209008
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
    NIDA:209008\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZDA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GUILD ASSOCIATES, INC.
  • Organization Department
  • Organization DUNS
    001004258
  • Organization City
    DUBLIN
  • Organization State
    OH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    430161234
  • Organization District
    UNITED STATES